Novavax seeks EUA for its vaccine

By Red Mendoza

Aug 10, 2021 12:28 am

AMERICAN drugmaker Novavax has applied for an emergency use authorization (EUA) for its Covovax or NVX-Cov2373 vaccine.

Food and Drug Administration (FDA) Director General Rolando Enrique Domingo said during a briefing on Monday the agency started evaluating the vaccine after its local distributor, Faberco Life Sciences Inc., submitted some required documents last week.

Food and Drug Administration (FDA) Director General Rolando Enrique Domingo. File Photo

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

PNP to charge Quiboloy coddlers

PH ship ends watch on flashpoint reef

AI 'accelerating climate crisis,' expert warns

House starts budget plenary debates

PAO boosts partnership with Muslim community

Go commits to help crises-hit communities

6 dead from storm, southwest monsoon